These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 24939640)
1. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram. Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640 [TBL] [Abstract][Full Text] [Related]
2. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals. Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394 [TBL] [Abstract][Full Text] [Related]
3. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals. Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778 [TBL] [Abstract][Full Text] [Related]
4. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying. Patil SP; Modi SR; Bansal AK Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol cocrystals with enhanced solubility and tabletability. Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539 [TBL] [Abstract][Full Text] [Related]
7. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance. Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823 [TBL] [Abstract][Full Text] [Related]
8. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties. Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer. Tomaszewska I; Karki S; Shur J; Price R; Fotaki N Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143 [TBL] [Abstract][Full Text] [Related]
10. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. Boksa K; Otte A; Pinal R J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421 [TBL] [Abstract][Full Text] [Related]
11. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Chow SF; Chen M; Shi L; Chow AH; Sun CC Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146 [TBL] [Abstract][Full Text] [Related]
12. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations. Kumar S; Gupta A; Prasad R; Singh S Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053 [TBL] [Abstract][Full Text] [Related]
13. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method. Chaudhari KR; Savjani JK; Savjani KT; Shah H Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497 [TBL] [Abstract][Full Text] [Related]
14. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide. Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368 [TBL] [Abstract][Full Text] [Related]
15. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects. Cui W; He Z; Zhang Y; Fan Q; Feng N AAPS PharmSciTech; 2019 Feb; 20(3):115. PubMed ID: 30771018 [TBL] [Abstract][Full Text] [Related]
16. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization. Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510 [TBL] [Abstract][Full Text] [Related]
19. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement. Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632 [TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods. do Amaral LH; do Carmo FA; Amaro MI; de Sousa VP; da Silva LCRP; de Almeida GS; Rodrigues CR; Healy AM; Cabral LM AAPS PharmSciTech; 2018 Aug; 19(6):2687-2699. PubMed ID: 29968042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]